Lv1
30 积分 2022-05-16 加入
OK
TCRs and AI: the future is now
8天前
已完结
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
11天前
已完结
CAR T therapy beyond cancer: the evolution of a living drug
15天前
已完结
CAR T Cells — A New Horizon for Autoimmunity?
24天前
已完结
CAR T-cell therapy in autoimmune diseases
24天前
已完结
Chun Wang on oncology in China
1个月前
已完结
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells
2个月前
已完结
High Efficacy and Excellent Safety Profile of Actalycabtagene Autoleucel, a Humanized CD19 CAR-T Product in r/r B-Cell Malignancies: A Phase II Pivotal Trial
2个月前
已关闭
Strategies for manufacturing cell therapy products aligned with patient needs
4个月前
已完结
Generation of CAR T-cells using γ-retroviral vector
4个月前
已完结
皖公网安备34019202002308
